Concepedia

Utility of serum free light chain measurements in multiple myeloma patients not achieving complete response to therapy

Muhamad Alhaj Moustafa, S. Vincent Rajkumar, Angela Dispenzieri, Morie A. Gertz, Martha Q. Lacy, Francis K. Buadi, Yi L. Hwa, David Dingli, Prashant Kapoor, Suzanne R. Hayman,

Leukemia · 2015 · 34 citations · 21 references

DOIFull text

Open access

Concepts

References

21

Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib: A multicenter international myeloma working group study

Shaji Kumar, J H Lee, Juan José Lahuerta et al. · Leukemia · 2011 · 718 citations · Full text

, , +9

Serum free light chain ratio is an independent risk factor for progression in monoclonal gammopathy of undetermined significance

S. Vincent Rajkumar, Robert A. Kyle, Terry M. Therneau et al. · Blood · 2005 · 690 citations · Full text

Progression of Monoclonal Gammopathy with Undetermined Significance to Multiple Myeloma Diagnosed by Kidney Biopsy: A Case Report

Jin Hae Kim, Ji Won Kim, Young Nam Kim et al. · Case Reports in Nephrology and Dialysis · 2015 · 539 citations · Full text

, , +12

Immunoglobulin free light chain ratio is an independent risk factor for progression of smoldering (asymptomatic) multiple myeloma

Angela Dispenzieri, Robert A. Kyle, Jerry A. Katzmann et al. · Blood · 2007 · 423 citations · Full text

Serum free light-chain measurements for identifying and monitoring patients with nonsecretory multiple myeloma

Mark T. Drayson, Lian X. Tang, Roger Drew et al. · Blood · 2001 · 419 citations